The Autotaxin Inhibitor GLPG1690 Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice

被引：0
|
作者：
Murgo, A. [1 ]
Canciani, B. [2 ]
Fragni, D. [1 ]
Donetti, E. [2 ]
Civelli, M. [1 ]
Villetti, G. [1 ]
Miglietta, D. [1 ]
机构：
[1] Chiesi Farmaceut SpA, Corp Preclin R&D, Parma, Italy
[2] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5239
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The Integrin Inhibitor Cilengitide and Bleomycin-Induced Pulmonary Fibrosis Cilengitide and Bleomycin-Induced Pulmonary Fibrosis
    Ritzenthaler, Jeffrey D.
    Zhang, Michael
    Torres-Gonzalez, Edilson
    Roman, Jesse
    LUNG, 2020, 198 (06) : 947 - 955
  • [22] Atrial Natriuretic Peptide Attenuates Bleomycin-Induced Pulmonary Fibrosis In Mice
    Okamoto, A.
    Konishi, K.
    Nojiri, T.
    Hosoda, H.
    Tokudome, T.
    Asai, K.
    Hirata, K.
    Kangawa, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [23] Antiflammin-1 attenuates bleomycin-induced pulmonary fibrosis in mice
    Wei Liu
    Jing Wan
    Jian-Zhong Han
    Chen Li
    Dan-Dan Feng
    Shao-Jie Yue
    Yan-Hong Huang
    Yi Chen
    Qing-Mei Cheng
    Yang Li
    Zi-Qiang Luo
    Respiratory Research, 14
  • [24] Antiflammin-1 attenuates bleomycin-induced pulmonary fibrosis in mice
    Liu, Wei
    Wan, Jing
    Han, Jian-Zhong
    Li, Chen
    Feng, Dan-Dan
    Yue, Shao-Jie
    Huang, Yan-Hong
    Chen, Yi
    Cheng, Qing-Mei
    Li, Yang
    Luo, Zi-Qiang
    RESPIRATORY RESEARCH, 2013, 14
  • [25] Safety, Pharmacokinetics, and Pharmacodynamics of the Autotaxin Inhibitor GLPG1690 in Healthy Subjects: Phase 1 Randomized Trials
    van der Aar, Ellen
    Desrivot, Julie
    Dupont, Sonia
    Heckmann, Bertrand
    Fieuw, Ann
    Stutvoet, Simone
    Fagard, Liesbeth
    Van de Wal, Karen
    Helmer, Eric
    JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (10): : 1366 - 1378
  • [26] Favorable human safety, pharmacokinetics and pharmacodynamics of the autotaxin inhibitor GLPG1690, a potential new treatment in COPD
    Van der Aar, Ellen
    Fagard, Liesbeth
    Desrivot, Julie
    Dupont, Sonia
    Heckmann, Bertrand
    Blanque, Roland
    Gheyle, Lien
    Ralic, Jovica
    Vanhoutte, Frederic
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [27] The Integrin Inhibitor Cilengitide and Bleomycin-Induced Pulmonary FibrosisCilengitide and Bleomycin-Induced Pulmonary Fibrosis
    Jeffrey D. Ritzenthaler
    Michael Zhang
    Edilson Torres-Gonzalez
    Jesse Roman
    Lung, 2020, 198 : 947 - 955
  • [28] Effects of neutrophil elastase inhibitor on bleomycin-induced pulmonary fibrosis in mice
    Taooka, Y
    Maeda, A
    Hiyama, K
    Ishioka, S
    Yamakido, M
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (01) : 260 - 265
  • [29] A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice
    Takemasa, Akihiro
    Ishii, Yoshiki
    Fukuda, Takeshi
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40 (06) : 1475 - 1482
  • [30] THE CALPAIN INHIBITOR CALPEPTIN PREVENTS BLEOMYCIN-INDUCED PULMONARY FIBROSIS IN MICE
    Tabata, Chiharu
    Tabata, Rie
    Shibata, Eisuke
    Kanemura, Shingo
    Mikami, Koji
    Nogi, Yoshitaka
    Masachika, Eriko
    Okuwa, Hisaya
    Honda, Miki
    Kamiya, Hitomi
    Maeda, Risa
    Terada, Takayuki
    Tamura, Kunihiro
    Nakano, Takashi
    RESPIROLOGY, 2013, 18 : 201 - 201
12345